Top Markets
#1 ADO Protocol ADO Protocol +193.34%
#2 Islamic Coin Islamic Coin +155.37%
#3 GoPlus Security GoPlus Security +44.27%
#4 GAIB AID GAIB AID +24.67%
#5 SkyAI SkyAI +14.39%
#6 Verus Coin Verus Coin +13.64%
#7 o1.exchange o1.exchange +12.48%
#8 Tutorial Tutorial +12.27%
#9 Casper Network Casper Network +12.23%
#10 Pons Pons +12.22%
Coin of the day
ADO Protocol ADO Protocol
설정
언어
한국어
통화
USD
테마
Anew Medical, Inc. Anew Medical, Inc.

Anew Medical, Inc.

WENA
주식 순위 #33455
Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing... Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing innovative treatments for conditions affecting the brain and nervous system, age-related illnesses, and specialized diagnostic tools. Their pipeline includes advanced cell and gene therapies specifically designed to alleviate symptoms of aging-related conditions, such as dementia, Alzheimer's disease, and various neuromuscular disorders. Additionally, Anew Medical is engaged in developing biologics and biosimilars for cancer treatment, alongside research into therapies targeting melanocortin receptors. A key strategic alliance exists with Japan's Okinawa Research Center, focusing on the collaborative research and development of Klotho gene therapy. This initiative aims to extend human longevity and diminish the impact of age-related diseases. The company maintains its headquarters in Omaha, Nebraska.
주가
$0.5099
마지막 동기화: 2024-10-15
시가총액
$7.60M
변동 (1일)
2.02%
변동 (1년)
0.00%
국가
US
거래 Anew Medical, Inc. (WENA)

카테고리

Healthcare
Anew Medical, Inc. (WENA)의 수익
Jun 2024 기준 수익 TTM: $114.12K
Anew Medical, Inc.의 최신 재무 보고서에 따르면 회사의 현재 수익은 $114.12K입니다. 2022년에 회사는 $1.56M의 수익을 올렸으며 이는 2021년의 수익 $-1.11M과 증가입니다. 이 페이지에 표시된 수익은 이자 및 세금 공제 전 수익으로, 즉 EBIT입니다.
Anew Medical, Inc.의 수익 기록 (2021 ~ 2026)
연말 수익
연도 수익 변화
2026 (TTM) $114.12K -94.40%
2023 $2.04M 30.95%
2022 $1.56M -240.25%
2021 $-1.11M 0.00%
유사 기업 또는 경쟁사의 수익
회사 수익 수익 차이 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B 4,622,261.26%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B 1,709,242.25%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B 2,633,790.84%
BE